Advertisement
The PLoS Medicine Debate

Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment

  • Sofia Gruskin mail,

    sgruskin@hsph.harvard.edu

    Affiliation: Program on International Health and Human Rights, Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Zyde Raad

    Affiliation: Program on International Health and Human Rights, Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Published: September 28, 2010
  • DOI: 10.1371/journal.pmed.1000310
  • Published in PLOS Medicine

About the Authors

Sofia Gruskin, Zyde Raad
Program on International Health and Human Rights, Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America

Corresponding Author

Email: sgruskin@hsph.harvard.edu

Competing Interests

SG is director of and ZR is program manager at the Program on International Health and Human Rights (PIHHR) at Harvard School of Public Health. PIHHR has received funding from the Merck Company Foundation for a several-year project exploring the roles and responsibilities of the pharmaceutical industry as well as other state and non-state actors with regard to alleviating disease burdens worldwide.

Author Contributions

ICMJE criteria for authorship read and met: SG ZR. Agree with the manuscript's results and conclusions: SG ZR. Wrote the first draft of the paper: ZR. Contributed to the writing of the paper: SG ZR.